VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TOI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TOIThe Oncology Institute, Inc.
$5.80$5.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTOIQuarterly Financials

The Oncology Institute, Inc. (TOI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

The Oncology Institute, Inc. (TOI) quarterly income statement — complete revenue, gross profit & net income history

TOI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue147.44M141.96M136.56M119.8M104.41M100.27M99.9M98.58M94.67M85.79M82.03M80.22M76.19M71.42M64.98M60.92M55.16M52.3M52.27M49.84M
Revenue Growth %41.22%41.58%36.7%21.53%10.29%16.88%21.78%22.88%24.25%20.11%26.25%31.69%38.13%36.56%24.3%22.22%13.55%6.82%10.64%5.42%
Cost of Goods Sold125.74M119.19M117.64M102.3M87.16M85.63M85.53M85.55M82.7M71.41M66.06M65.11M62.09M55.8M51.98M49.78M42.84M43.97M40.85M38.95M
COGS % of Revenue85.28%83.96%86.15%85.39%83.48%85.4%85.62%86.79%87.36%83.24%80.52%81.16%81.5%78.12%79.99%81.71%77.66%84.07%78.15%78.15%
Gross Profit21.7M22.77M18.92M17.5M17.25M14.64M14.37M13.03M11.97M14.38M15.98M15.12M14.1M15.63M13M11.14M12.32M8.33M11.42M10.89M
Gross Margin %14.72%16.04%13.85%14.61%16.52%14.6%14.38%13.21%12.64%16.76%19.48%18.84%18.5%21.88%20.01%18.29%22.34%15.93%21.85%21.85%
Gross Profit Growth %25.8%55.54%31.7%34.35%44.11%1.79%-10.09%-13.83%-15.11%-8%22.91%35.68%14.42%87.56%13.81%2.31%20.78%-17.11%19.32%14.77%
Operating Expenses28.21M29.67M26.97M28.71M27.16M26.57M28.22M29.39M29.94M29.67M29.9M30.05M46.97M40.71M33.1M29.45M30.79M49.16M13.58M12.01M
OpEx % of Revenue19.13%20.9%19.75%23.97%26.01%26.49%28.25%29.81%31.63%34.58%36.45%37.46%61.64%56.99%50.94%48.33%55.82%94%25.98%24.09%
Selling, General & Admin28.21M28.04M25.25M025.38M24.86M0000000031.96M28.35M29.81M48.24M12.73M11.21M
SG&A % of Revenue19.13%19.75%18.49%-24.31%24.79%--------49.19%46.53%54.03%92.24%24.35%22.49%
Research & Development00000000000000000000
R&D % of Revenue--------------------
Other Operating Expenses01000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K987K920K850K794K
Operating Income-6.51M-6.91M-8.05M-11.21M-9.91M-11.93M-13.85M-16.36M-17.97M-15.29M-13.93M-14.94M-32.87M-25.08M-20.1M-18.3M-18.47M-40.83M-2.16M-1.12M
Operating Margin %-4.42%-4.87%-5.9%-9.36%-9.49%-11.9%-13.87%-16.6%-18.98%-17.82%-16.97%-18.62%-43.14%-35.11%-30.93%-30.05%-33.49%-78.07%-4.13%-2.24%
Operating Income Growth %34.29%42.1%41.86%31.49%44.85%21.97%0.52%-9.55%45.32%39.04%30.71%18.39%-77.94%38.58%-831.71%-1540.14%-953.68%-719.43%-203.28%-898.75%
EBITDA-4.9M-5.28M-6.33M-9.41M-8.13M-10.22M-12.28M-14.85M-16.48M-13.71M-12.23M-13.61M-31.6M-23.89M-18.96M-17.21M-17.48M-39.91M-1.31M-322K
EBITDA Margin %-3.32%-3.72%-4.64%-7.85%-7.78%-10.19%-12.29%-15.06%-17.41%-15.98%-14.9%-16.96%-41.47%-33.44%-29.18%-28.24%-31.7%-76.31%-2.5%-0.65%
EBITDA Growth %39.74%48.4%48.44%36.64%50.69%25.45%-0.43%-9.09%47.84%42.6%35.52%20.91%-80.73%40.15%-1350.88%-5243.48%-1691.39%-851.87%-1708.67%-134.22%
D&A (Non-Cash Add-back)1.62M1.63M1.72M1.8M1.78M1.71M1.57M1.52M1.49M1.58M1.7M1.33M1.27M1.19M1.13M1.1M987K920K850K794K
EBIT-6.51M-5.59M-14.58M-11.21M-14.02M-12.01M-13.85M-16.36M-17.97M-15.4M-13.88M-14.88M-16M-15.83M-1.2M-5.42M19.54M-12.56M-2.1M4.07M
Net Interest Income-1.93M-1.92M-1.92M-1.87M-5.57M-1.17M-2.23M-2.12M-1.99M-1.94M-1.75M-1.64M-1.44M-2.45M-1.5M-61K-74K-60K-78K-81K
Interest Income0000000000940K1.03M1.21M0000000
Interest Expense1.93M1.92M1.92M1.87M5.57M1.17M2.23M2.12M1.99M1.94M2.69M2.67M2.65M2.45M1.5M61K74K60K78K81K
Other Income/Expense4.02M-601K-8.45M-5.93M-9.67M-1.25M-2.26M885K-1.92M-3.78M-3.36M-1.86M2.91M13.71M17.4M12.82M37.94M28.21M-24K5.1M
Pretax Income-2.49M-7.51M-16.5M-17.14M-19.59M-13.18M-16.11M-15.48M-19.89M-19.07M-17.28M-16.8M-29.95M-11.37M-2.7M-5.49M19.47M-12.62M-2.18M3.98M
Pretax Margin %-1.69%-5.29%-12.09%-14.31%-18.76%-13.15%-16.13%-15.7%-21.01%-22.23%-21.07%-20.94%-39.31%-15.92%-4.15%-9%35.29%-24.14%-4.17%7.99%
Income Tax000-131K00000-314K135K99K44K-367K-24K-32K180K-2.47M799K780K
Effective Tax Rate %0%0%0%0.76%0%0%0%0%0%1.65%-0.78%-0.59%-0.15%3.23%0.89%0.58%0.92%19.55%-36.63%19.57%
Net Income-2.49M-7.51M-16.5M-17.01M-19.59M-13.18M-16.11M-15.48M-19.89M-18.75M-17.42M-16.9M-30M-11.01M-2.67M-5.45M19.29M-10.16M-2.98M3.21M
Net Margin %-1.69%-5.29%-12.09%-14.2%-18.76%-13.15%-16.13%-15.7%-21.01%-21.86%-21.23%-21.06%-39.37%-15.41%-4.12%-8.95%34.96%-19.42%-5.7%6.43%
Net Income Growth %87.28%43.04%-2.43%-9.88%1.53%29.71%7.5%8.39%33.7%-70.38%-551.42%-209.87%-255.54%-8.38%10.27%-270.14%2036.35%-110.75%-340.86%214.77%
Net Income (Continuing)-2.49M-7.51M-16.5M-17.01M-19.59M-13.18M-16.11M-15.48M-19.89M-18.75M-17.42M-16.9M-30M-11.01M-2.67M-5.45M19.29M-10.16M-2.98M3.21M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.02-0.04-0.14-0.15-0.21-0.14-0.18-0.17-0.22-0.21-0.19-0.23-0.41-0.11-0.03-0.070.21-0.15-0.040.05
EPS Growth %90.48%71.43%22.22%11.76%4.55%33.33%5.26%26.09%46.34%-90.91%-465.48%-207.9%-295.24%26.67%16%-249.4%1490.73%50%52.44%224.68%
EPS (Basic)-0.02-0.04-0.14-0.15-0.21-0.14-0.18-0.17-0.22-0.21-0.19-0.23-0.41-0.13-0.03-0.070.22-0.15-0.040.05
Diluted Shares Outstanding1.02B1.01B974.75M932.04M77.1M75.66M75.52M74.75M74.23M73.47M73.47M74.12M73.45M85.59M79.58M73M76.25M69.95M74.59M66.02M
Basic Shares Outstanding1.02B1.01B974.75M932.04M77.1M75.66M75.52M74.75M74.23M73.47M73.47M74.12M73.45M72.75M79.58M73M73.25M69.95M74.59M66.02M
Dividend Payout Ratio--------------------